Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased HDAC Activity and c-MYC Expression Mediate Acquired Resistance to WEE1 Inhibition in Acute Leukemia
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-03-05
DOI
10.3389/fonc.2020.00296
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine
- (2018) Tamara B. Garcia et al. LEUKEMIA RESEARCH
- A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute Leukemia
- (2017) Tamara B. Garcia et al. MOLECULAR CANCER THERAPEUTICS
- The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma
- (2015) Barbara Banelli et al. CELL CYCLE
- Intratumoral Heterogeneity: From Diversity Comes Resistance
- (2015) A. Pribluda et al. CLINICAL CANCER RESEARCH
- Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
- (2015) Khanh Do et al. JOURNAL OF CLINICAL ONCOLOGY
- AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair
- (2015) James B. Ford et al. Oncotarget
- Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma
- (2015) Sujatha Venataraman et al. Oncotarget
- Comparison of Varicella-Zoster Virus RNA Sequences in Human Neurons and Fibroblasts
- (2014) N. L. Baird et al. JOURNAL OF VIROLOGY
- A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
- (2014) L Zhou et al. LEUKEMIA
- Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
- (2014) Peter S Harris et al. Molecular Cancer
- Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo, Independent of p53 Functionality
- (2013) A. A. Van Linden et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
- (2013) A. D. Guertin et al. MOLECULAR CANCER THERAPEUTICS
- The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
- (2013) Kristian W Pajtler et al. Acta Neuropathologica Communications
- RNAi screening of the kinome with cytarabine in leukemias
- (2012) R. Tibes et al. BLOOD
- Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia
- (2012) C C Porter et al. LEUKEMIA
- Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption
- (2012) H. Beck et al. MOLECULAR AND CELLULAR BIOLOGY
- H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes
- (2012) Kiran Mahajan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mechanisms of drug resistance in kinases
- (2011) Rina Barouch-Bentov et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Fast and SNP-tolerant detection of complex variants and splicing in short reads
- (2010) T. D. Wu et al. BIOINFORMATICS
- MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil
- (2010) Hiroshi Hirai et al. CANCER BIOLOGY & THERAPY
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
- (2010) Halfdan Beck et al. JOURNAL OF CELL BIOLOGY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
- (2009) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Interfering RNA-mediated purine analog resistance for in vitro and in vivo cell selection
- (2008) C. C. Porter et al. BLOOD
- Global Regulation of Nucleotide Biosynthetic Genes by c-Myc
- (2008) Yen-Chun Liu et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started